Made with ❤️ by True Sparrow

Bringing you the latest funding data

Anbogen

Last funding round

Raised
$12,500,000
Round
Series A

Funding News (2)

Feb 1 2024FinSMEs

Startup details

Anbogen

Anbogen

Anbogen Therapeutics is a clinical-stage biotechnology company based in Taipei, Taiwan, dedicated to developing precision anti-cancer drugs to cure cancers and improve the lives of cancer patients worldwide.
www.anbogen.com
Taipei, Taiwan
Established in 2019
11-50 People
Healthcare, Drug Discovery and Delivery

Founders

TsungKai (Angus) Wu

TsungKai (Angus) Wu

Vice President Of Business Development

San Diego, California, United States

Investment details

Raised
$12,500,000
Round
Series A
Investors
China Development Industrial Bank (CDIB)
LEAD
National Development Fund

Funding News (1)

Jan 31 2024PR Newswire

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from Taiwan

Jun2024
1

1 week ago

XREX raised $18.8M from National Development Fund and 8 others
Taipei-based XREX is a blockchain-enabled financial institution offering enterprise-grade banking services to SMBs in emerging markets and novice-friendly financial services globally.
XREX

Founders

Wayne Huang,

Winston Hsiao

In News

PR Newswire
2

2 months ago

iKala raised a $20.8M Series B led by Chunghwa Telecom
Taiwan-based iKala offers AI-driven cloud services and marketing technology to enterprises, including Fortune 500 firms.
iKala

Founders

Sega Cheng

In News

PR Newswire
3

3 months ago

H2U Corp raised a $10M Series B led by Standard Foods and 1 other
Taiwan-based H2U promotes Lifestyle Medicine through AI-driven precision nutrition and holistic health solutions.

Founders

SAXON CHEN

In News

Macau Business
PR Newswire
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.